Interpore Cross
This article was originally published in The Gray Sheet
Executive Summary
Spinal implant maker will acquire AOM-CDO system for placing reinforcing substances inside bony structures such as spinal vertebrae through a $21.3 mil. agreement with privately held OsteoMedix, announced May 31. Introduced in mid-2000, the minimally invasive device allows treatment of pain from vertebral compression fractures, according to Interpore. Expected to close by July 31, the deal calls for Interpore to pay $8 mil. in cash and about $2.4 mil. in Interpore stock, which closed May 30 at $5.53 per share. AOM had about $1.2 mil. in sales in 2000